Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Edison Investment Research
$10.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Stratec Biomedical AG confirms FY 2014 outlook and confirms medium-term financial forecast for years through to 2017


Wednesday, 23 Jul 2014 01:35am EDT 

Stratec Biomedical AG:Continues to expect for FY 2014 substantial sales growth compared with FY 2013 financial, accompanied by slight increase in EBIT margin.Says medium-term financial forecast for years through to 2017 provides for average annual sales growth of 8 pct to 12 pct based on volume of sales generated in FY 2013. 

Company Quote

44.65
 --
30 Apr 2015